GWPH


GW Pharmaceuticals (GWPH): Epidiolex Will Be Approved Much Before the PDUFA Date, Bets Cantor

Cantor’s Elemer Piros now expects 52% in return potential for GWPH stock and sets a 100% probability of success for Epidiolex.

GW Pharmaceuticals (GWPH) Lead Drug’s Green Light Just Around the Corner? Cowen Joins the Conversation

On back of yesterday’s positive briefing documents, Cowen’s Phil Nadeau roots for FDA approval.

Why GW Pharmaceuticals (GWPH) Stock Is Posting Strong Gains Today

GW Pharmaceuticals (NASDAQ:GWPH) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 11% upturn. …

Philip Hempleman Hits the Ground Running in Helios and Matheson Analytics Inc (HMNY), GW Pharmaceuticals PLC- ADR (GWPH)

The hedge fund firm founder is stepping into tech stock HMNY and biopharma stock GWPH; here’s how these Q4 moves measure up against the word on the Street.

Cowen Remains Bullish on GW Pharmaceuticals PLC- ADR (GWPH) Despite Unsuccessful Phase 2 Trial in Focal Seizures

If you’ve been waiting patiently on the sidelines for a pullback in GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), it’s here. The drug maker’s shares …

Here’s Why GW Pharmaceuticals PLC- ADR (GWPH) Tumbles in After Hours Trading

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) tumbled nearly 5% in after-hours trading Wednesday, after the drug maker announced negative results with GWP42006 in …

Stock Update (NASDAQ:GWPH): GW Pharmaceuticals PLC- ADR Has Eyes on Marketing Lead Cannabinoid Asset in Europe

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) is aiming for an EMA marketing green light for Epidiolex, its lead cannabidiol or CBD product candidate, designed …

Stock Update (NASDAQ:GWPH): GW Pharmaceuticals PLC- ADR NDA Filing for Epidiolex Garners FDA Priority Review

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) investors will be smiling to hear the drug maker’s good news today: FDA acceptance for filing with Priority …

Zogenix, Inc. (ZGNX) Gain Is GW Pharmaceuticals PLC- ADR (GWPH) Pain

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares tumble nearly 9% in Friday’s trading session, following the news that competitor Zogenix, Inc. (NASDAQ:ZGNX) achieved impressive results …

Cantor Counts on GW Pharmaceuticals PLC- ADR (GWPH) Upcoming Catalysts

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares were falling 2% yesterday after the biotech company handed over its third-fiscal quarter print for the year, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts